| HIST1H1C |
HIST1H1C, H1F2: Histone H1.2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
1.305 |
Evidence |
|
| SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
1.305 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
1.305 |
Evidence |
|
| RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.305 |
Evidence |
|
| IL4 |
IL4: Interleukin-4 precursor |
STOM |
STOM, BND7, EPB72: Erythrocyte band 7 integral membrane protein |
1.305 |
Evidence |
|
| ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
CHTF18 |
RUVBL, CHTF18: Protein CTF18 homolog. |
1.305 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.305 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
KRT6E |
KRT6C, KRT6E: Keratin, type II cytoskeletal 6C |
1.305 |
Evidence |
|
| CASP6 |
CASP6, MCH2: Caspase-6 precursor |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
1.305 |
Evidence |
|
| EPO |
EPO: Erythropoietin precursor |
FGFR2 |
IPI00218422 |
1.305 |
Evidence |
|
| ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
1.305 |
Evidence |
|
| EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
C6 |
C6: Complement component C6 precursor |
1.305 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
1.305 |
Evidence |
|
| LEPR |
LEPR, DB, OBR: Leptin receptor precursor |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
1.305 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.305 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
KIAA0031 |
EFTUD2, KIAA0031, SNRP116: 116 kDa U5 small nuclear ribonucleoprotein component |
1.305 |
Evidence |
|
| C8G |
C8G: Complement component C8 gamma chain precursor |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
1.305 |
Evidence |
|
| VCAM1 |
VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
1.305 |
Evidence |
|
| CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
LIPG |
LIPG, UNQ387/PRO719: Endothelial lipase precursor |
1.305 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
FAF1 |
FAF1, CGI-03: FAS-associated factor 1 |
1.305 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
RNF20 |
|
1.305 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RB1 |
RB1: Retinoblastoma-associated protein |
1.305 |
Evidence |
|
| ZCCHC3 |
ZCCHC3, C20orf99: Zinc finger CCHC domain-containing protein 3 |
STAT3 |
|
1.305 |
Evidence |
|
| BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
1.305 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
1.302 |
Evidence |
|
- 
- 
-